Literature DB >> 18292307

Selective blockade of microRNA processing by Lin28.

Srinivas R Viswanathan1, George Q Daley, Richard I Gregory.   

Abstract

MicroRNAs (miRNAs) play critical roles in development, and dysregulation of miRNA expression has been observed in human malignancies. Recent evidence suggests that the processing of several primary miRNA transcripts (pri-miRNAs) is blocked posttranscriptionally in embryonic stem cells, embryonal carcinoma cells, and primary tumors. Here we show that Lin28, a developmentally regulated RNA binding protein, selectively blocks the processing of pri-let-7 miRNAs in embryonic cells. Using in vitro and in vivo studies, we found that Lin28 is necessary and sufficient for blocking Microprocessor-mediated cleavage of pri-let-7 miRNAs. Our results identify Lin28 as a negative regulator of miRNA biogenesis and suggest that Lin28 may play a central role in blocking miRNA-mediated differentiation in stem cells and in certain cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292307      PMCID: PMC3368499          DOI: 10.1126/science.1154040

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  21 in total

1.  Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.

Authors:  Richard I Gregory; Thimmaiah P Chendrimada; Neil Cooch; Ramin Shiekhattar
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

2.  Post-transcriptional regulation of the let-7 microRNA during neural cell specification.

Authors:  F Gregory Wulczyn; Lena Smirnova; Agnieszka Rybak; Christine Brandt; Erik Kwidzinski; Olaf Ninnemann; Michael Strehle; Andrea Seiler; Stefan Schumacher; Robert Nitsch
Journal:  FASEB J       Date:  2006-12-13       Impact factor: 5.191

3.  Post-transcriptional regulation of microRNA expression.

Authors:  Gregor Obernosterer; Philipp J F Leuschner; Mattias Alenius; Javier Martinez
Journal:  RNA       Date:  2006-05-31       Impact factor: 4.942

4.  Localization of the developmental timing regulator Lin28 to mRNP complexes, P-bodies and stress granules.

Authors:  Erica Balzer; Eric G Moss
Journal:  RNA Biol       Date:  2007-04-30       Impact factor: 4.652

5.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

6.  The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA.

Authors:  E G Moss; R C Lee; V Ambros
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

7.  Impaired microRNA processing enhances cellular transformation and tumorigenesis.

Authors:  Madhu S Kumar; Jun Lu; Kim L Mercer; Todd R Golub; Tyler Jacks
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

8.  The transcriptome profile of human embryonic stem cells as defined by SAGE.

Authors:  Mark Richards; Siew-Peng Tan; Jee-Hian Tan; Woon-Khiong Chan; Ariff Bongso
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

9.  let-7 regulates self renewal and tumorigenicity of breast cancer cells.

Authors:  Fengyan Yu; Herui Yao; Pengcheng Zhu; Xiaoqin Zhang; Qiuhui Pan; Chang Gong; Yijun Huang; Xiaoqu Hu; Fengxi Su; Judy Lieberman; Erwei Song
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

10.  The expression profile of microRNAs in mouse embryos.

Authors:  Junichi Mineno; Sachiko Okamoto; Tatsuya Ando; Masahiro Sato; Hideto Chono; Hiroyuki Izu; Masanori Takayama; Kiyozo Asada; Oleg Mirochnitchenko; Masayori Inouye; Ikunoshin Kato
Journal:  Nucleic Acids Res       Date:  2006-03-31       Impact factor: 16.971

View more
  715 in total

Review 1.  Small RNAs have a big impact on regeneration.

Authors:  Elizabeth J Thatcher; James G Patton
Journal:  RNA Biol       Date:  2010-05-14       Impact factor: 4.652

Review 2.  Post-transcriptional regulation in metabolic diseases.

Authors:  Wook Kim; Eun Kyung Lee
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

3.  Molecular basis for interaction of let-7 microRNAs with Lin28.

Authors:  Yunsun Nam; Casandra Chen; Richard I Gregory; James J Chou; Piotr Sliz
Journal:  Cell       Date:  2011-11-10       Impact factor: 41.582

4.  LIN28B promotes colon cancer progression and metastasis.

Authors:  Catrina E King; Miriam Cuatrecasas; Antoni Castells; Antonia R Sepulveda; Ju-Seog Lee; Anil K Rustgi
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

5.  Characterization and expression of lin-28a involved in lin28/let-7signal pathway during early development of P. olivaceus.

Authors:  Yuanshuai Fu; Lina Gao; Zhiyi Shi; Feng You; Junling Zhang; Wenjuan Li
Journal:  Fish Physiol Biochem       Date:  2017-12-07       Impact factor: 2.794

6.  The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7.

Authors:  Steven G Chaulk; Victoria J Lattanzi; Samantha E Hiemer; Richard P Fahlman; Xaralabos Varelas
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

Review 7.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

Review 8.  Origins and Mechanisms of miRNAs and siRNAs.

Authors:  Richard W Carthew; Erik J Sontheimer
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

9.  Modulation of LIN28B/Let-7 Signaling by Propranolol Contributes to Infantile Hemangioma Involution.

Authors:  Ezinne Francess Mong; Kemal Marc Akat; John Canfield; John Lockhart; Jeffrey VanWye; Andrew Matar; John C M Tsibris; June K Wu; Thomas Tuschl; Hana Totary-Jain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-03       Impact factor: 8.311

Review 10.  MicroRNAs in metabolic disease.

Authors:  Carlos Fernández-Hernando; Cristina M Ramírez; Leigh Goedeke; Yajaira Suárez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.